Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Clopidogrel 150 mg Tablet
Therapeutic Category
Cardiology, Cardiovascular, Hypertension/ Blood Pressure
Dosage Form
Tablet
Packaging Type
Alu Alu
Packaging
10*10
Price
₹75/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Clopiside 150 Tablet contains Clopidogrel 150 mg, an antiplatelet agent that helps prevent the formation of harmful blood clots. It acts by selectively inhibiting the binding of adenosine diphosphate (ADP) to its platelet receptor, thereby impeding platelet aggregation. This higher-strength formulation is especially used where increased antiplatelet action is required, such as in high-risk cardiovascular patients or post-angioplasty management. It is commonly prescribed to reduce the risk of stroke, heart attack, and other serious heart conditions.
Some commonly reported side effects include bruising, bleeding, headache, diarrhea, or gastric discomfort. Rare but serious effects may include severe bleeding, thrombocytopenia, or allergic reactions. Prompt medical attention is advised if unusual bleeding or signs of hypersensitivity occur.
Clopiside 150 is indicated for the prevention of thrombotic events in patients with acute coronary syndrome (ACS), including those undergoing percutaneous coronary intervention (PCI). It is also used in the secondary prevention of myocardial infarction, ischemic stroke, and in patients with established peripheral arterial disease.
Clopiside 150 should be taken strictly as advised by a physician. It should not be stopped abruptly without medical consultation. Caution is advised in patients with a history of bleeding disorders, recent surgery, or peptic ulcers. Avoid combining with other blood thinners unless prescribed.
Store in a cool, dry place, away from direct sunlight and moisture. Keep out of reach of children.
Composition : Clopidogrel 75 mg Tablet
Composition : Clopidogrel 75mg + Aspirin 150mg Tablet
Composition : Clopidogrel (75mg) + Aspirin (75mg) Tablet
Composition : Losartan 25mg Tablet
Composition : Losartan 50mg + Chlorthalidone 6.25mg Tablet
Composition : METOPROLOL SUCCINATE 50 MG + AMLODIPINE 5 MG Tablet
Composition : Metoprolol Succinate 25mg + Ramipril 2.5mg Tablet
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Clopidogrel 150mg Tablet has strong demand in the cardiovascular care segment, making it a profitable product for medical distributors, wholesalers, and pharma franchise partners looking to expand in the PCD pharma franchise market.
Medical distributors and wholesalers can benefit from the consistent demand for this formulation in heart care, stroke prevention support, and antiplatelet therapy management. It strengthens their cardiovascular portfolio.
Yes, Cafoli Lifecare offers PCD pharma franchise opportunities for Clopidogrel 150mg Tablet with monopoly rights, promotional support, quality packaging, competitive pricing, and reliable supply support for distributors and medical agencies.
Wholesalers and medical agencies benefit from steady demand in chronic cardiac care, attractive margins, strong prescription-based sales, and consistent market acceptance when partnering with Cafoli Lifecare.
Medical distributors, stockists, wholesalers, and pharma professionals interested in this cardiovascular formulation can contact Cafoli Lifecare to discuss PCD pharma franchise opportunities, bulk orders, pricing details, and distribution support services.